Figure 1.
The graph depicting the concentration of IL-1β following the treatment of OMM samples with artificial saliva, 200 nM NE, 100 nM NE, and 0.01% SLS (P < 0.01∗∗, P < 0.001∗∗∗) for 24 hours.
The graph depicting the concentration of IL-1β following the treatment of OMM samples with artificial saliva, 200 nM NE, 100 nM NE, and 0.01% SLS (P < 0.01∗∗, P < 0.001∗∗∗) for 24 hours.